Anidulafungin treatment for fluconazole-resistant Candida albicans vaginitis with cross-resistance to azoles: a case report

J Obstet Gynaecol. 2021 May;41(4):665-666. doi: 10.1080/01443615.2020.1732893. Epub 2020 Apr 21.

Authors

Damla Akdağ¹, Hüsnü Pullukçu¹, Tansu Yamazhan¹, Dilek Yeşim Metin², Oğuz Reşat Sipahi¹, Beyza Ener³, Meltem Işıkgöz Taşbakan¹

Affiliations

¹ Department of Infectious Diseases and Clinical Microbiology, Ege University Faculty of Medicine, Izmir, Turkey.
² Department of Medical Microbiology, Division of Mycology, Ege University Faculty of Medicine, Izmir, Turkey.
³ Department of Medical Microbiology, Uludag University Faculty of Medicine, Bursa, Turkey.

PMID: 32312119
DOI: 10.1080/01443615.2020.1732893

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anidulafungin / pharmacology*
Anidulafungin / therapeutic use*
Antifungal Agents / pharmacology*
Antifungal Agents / therapeutic use*
Azoles / pharmacology
Candida albicans / drug effects*
Candidiasis, Vulvovaginal / drug therapy*
Drug Resistance, Fungal
Female
Fluconazole / pharmacology
Humans
Microbial Sensitivity Tests
Turkey / epidemiology

Substances

Antifungal Agents
Azoles
Fluconazole
Anidulafungin